164 related articles for article (PubMed ID: 11328817)
21. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.
Delwel R; Funabiki T; Kreider BL; Morishita K; Ihle JN
Mol Cell Biol; 1993 Jul; 13(7):4291-300. PubMed ID: 8321231
[TBL] [Abstract][Full Text] [Related]
22. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
23. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract][Full Text] [Related]
24. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
Kreider BL; Orkin SH; Ihle JN
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6454-8. PubMed ID: 8341654
[TBL] [Abstract][Full Text] [Related]
25. ZEB represses transcription through interaction with the corepressor CtBP.
Postigo AA; Dean DC
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6683-8. PubMed ID: 10359772
[TBL] [Abstract][Full Text] [Related]
26. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
[TBL] [Abstract][Full Text] [Related]
27. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.
Zhang CL; McKinsey TA; Lu JR; Olson EN
J Biol Chem; 2001 Jan; 276(1):35-9. PubMed ID: 11022042
[TBL] [Abstract][Full Text] [Related]
28. The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein.
Takahashi S; Licht JD
Leukemia; 2002 Sep; 16(9):1755-62. PubMed ID: 12200691
[TBL] [Abstract][Full Text] [Related]
29. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
[TBL] [Abstract][Full Text] [Related]
30. Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP).
Hickabottom M; Parker GA; Freemont P; Crook T; Allday MJ
J Biol Chem; 2002 Dec; 277(49):47197-204. PubMed ID: 12372828
[TBL] [Abstract][Full Text] [Related]
31. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.
Vinatzer U; Taplick J; Seiser C; Fonatsch C; Wieser R
Br J Haematol; 2001 Sep; 114(3):566-73. PubMed ID: 11552981
[TBL] [Abstract][Full Text] [Related]
32. The transcription factor Evi-1.
Hirai H
Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
[TBL] [Abstract][Full Text] [Related]
33. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide.
Zhang Y; Sicot G; Cui X; Vogel M; Wuertzer CA; Lezon-Geyda K; Wheeler J; Harki DA; Muzikar KA; Stolper DA; Dervan PB; Perkins AS
Biochemistry; 2011 Dec; 50(48):10431-41. PubMed ID: 22039883
[TBL] [Abstract][Full Text] [Related]
34. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
[TBL] [Abstract][Full Text] [Related]
35. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
36. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
[TBL] [Abstract][Full Text] [Related]
37. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
[TBL] [Abstract][Full Text] [Related]
38. Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.
Fukuda S; Hoggatt J; Singh P; Abe M; Speth JM; Hu P; Conway EM; Nucifora G; Yamaguchi S; Pelus LM
Leukemia; 2015 Feb; 29(2):433-40. PubMed ID: 24903482
[TBL] [Abstract][Full Text] [Related]
39. Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III.
Roy P; Reavey E; Rayne M; Roy S; Abed El Baky M; Ishii Y; Bartholomew C
FEBS J; 2010 Jan; 277(2):441-52. PubMed ID: 20015077
[TBL] [Abstract][Full Text] [Related]
40. Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias.
Fontenay-Roupie M; Bouscary D; Melle J; ViguiƩ F; Picard F; Guesnu M; Dreyfus F
Hematol Cell Ther; 1997 Feb; 39(1):5-10. PubMed ID: 9088932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]